Dimitra Vyrla

TPL2 kinase is a suppressor of lung carcinogenesis

Katerina Gkirtzimanaki, Kalliopi Gkouskou, Urszula Oleksiewicz et al. · Proceedings of the National Academy of Sciences · 2013 · 51 citations · Full text

Tumor Microenvironment, Tpl2 Locus, Cell Signaling +14

Tumor progression locus 2/Cot is required for activation of extracellular regulated kinase in liver injury and toll-like receptor–induced TIMP-1 gene transcription in hepatic stellate cells in mice

María J. Perugorria, L. Murphy, Nicola Fullard et al. · Hepatology · 2012 · 42 citations

Neorogioltriol and Related Diterpenes from the Red Alga Laurencia Inhibit Inflammatory Bowel Disease in Mice by Suppressing M1 and Promoting M2-Like Macrophage Responses

Maria Daskalaki, Dimitra Vyrla, Maria Harizani et al. · Marine Drugs · 2019 · 35 citations · Full text

Enhanced therapeutic anti-tumor immunity induced by co-administration of 5-fluorouracil and adenovirus expressing CD40 ligand

Lina Liljenfeldt, Katerina Gkirtzimanaki, Dimitra Vyrla et al. · Cancer Immunology Immunotherapy · 2013 · 18 citations · Full text

Immunology, Tumor Immunity, Therapeutic Vaccine +7

TPL2 Kinase Is a Crucial Signaling Factor and Mediator of NKT Effector Cytokine Expression in Immune-Mediated Liver Injury

Dimitra Vyrla, Georgios Nikolaidis, Fiona Oakley et al. · The Journal of Immunology · 2016 · 12 citations